Lenskart Solutions Profit Jumps 182% to ₹228 Cr in Q1FY27; EBITDA Margin Expands
Lenskart Solutions reported strong Q1FY27 results with consolidated PAT surging 182% YoY to ₹228 crore and revenue growing 33.6% to ₹2,714 crore. EBITDA rose 61.3% to ₹589 crore with EBITDA margin expanding to 21.7% from 17.7%, while product margin crossed 70% for the first time. Operationally, the company added 132 net new stores, conducted 0.7 crore eye tests, and saw India SSSG of 18.3%, with ROCE improving to 23.2%.

*this image is generated using AI for illustrative purposes only.
Lenskart Solutions reported a consolidated net profit after tax (PAT) of ₹228 crore for the quarter ended June 30, 2026, marking a 182% surge year-on-year from ₹81 crore in Q1FY26. Consolidated revenue from operations grew 33.6% to ₹2,714 crore, driven by strong performance in both domestic and international segments. The robust top-line growth was accompanied by significant margin expansion, with consolidated EBITDA rising 61.3% to ₹589 crore and consolidated EBITDA margin improving to 21.7% from 17.7% in Q1FY26. Consolidated product margin crossed 70% for the first time at 70.3%. Return on Capital Employed (ROCE) improved to 23.2% in Q1FY27, up from 14.6% in FY26.
The Board of Directors approved these unaudited financial results on August 12, 2026. The company highlighted that operating cash flow reached ₹297 crore, comfortably covering store capex of ₹75 crore and plant capex of ₹132 crore, primarily for its Hyderabad manufacturing facility. This resulted in a positive net cash flow pre-M&A and equity of ₹116 crore. The net cash balance excluding IPO-related payables stood at ₹4,104 crore as of the quarter-end.
Financial Performance
The table below summarises the key financial metrics for the quarter, reflecting broad-based improvement across revenue, profitability, and margins.
| Metric | Q1FY27 | Q1FY26 | YoY Change |
|---|---|---|---|
| Consolidated Revenue | ₹2,714 Cr | ₹2,032 Cr | +33.6% |
| Consolidated PAT | ₹228 Cr | ₹81 Cr | +182.3% |
| Consolidated EBITDA | ₹589 Cr | ₹365 Cr | +61.3% |
| EBITDA Margin | 21.7% | 17.7% | +400 bps |
| Product Margin % | 70.3% | 68.7% | +160 bps |
Operational Highlights
The company conducted 0.7 crore eye tests in Q1FY27, a 39.8% increase year-on-year, with approximately half being first-time eye exams in India. Eyewear units sold rose 25.7% to 1.1 crore. Lenskart added 132 net new stores during the quarter, bringing the total active store count to 3,459. In India, same-store sales growth (SSSG) stood at 18.3%, while same-pin-code sales growth (SPSG) reached 24.3%, indicating that densification is generating incremental demand rather than cannibalizing existing stores.
Segment Analysis
India revenue grew 30.7% YoY to ₹1,531 crore, with EBITDA margin expanding to 21.4% from 19.4%. International revenue surged 38.0% to ₹1,203 crore, with EBITDA margin reaching 21.9% from 16.9%. The international segment's EBITDA (pre-IndAS 116) margin crossed 10% for the first time, reaching 10.6%, driven by scale and higher product margins of 77.1%.
What the Numbers Show
The divergence between standalone and consolidated profitability highlights the growing contribution of international operations and subsidiaries. Consolidated product margin hit 70.3%, sustained despite INR depreciation against RMB, due to increased in-house manufacturing. In-house frame manufacturing grew 54.8% YoY to 28 lakh units. The expansion of premium brands like Owndays and Meller, along with mass-market initiatives like the ₹500 Hustlr Club pair, demonstrates successful execution across both ends of the spectrum. ROCE improvement to 23.2% signals efficient capital deployment as idle cash from IPO proceeds begins generating operating returns.
Historical Stock Returns for Lenskart Solutions
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.47% | +3.34% | +8.77% | +25.42% | +45.48% | +45.48% |
How sustainable is the 70.3% product margin given the ongoing depreciation of the INR against the RMB and potential raw material cost fluctuations?
Will Lenskart's aggressive international expansion, particularly in markets with different regulatory frameworks, face new headwinds that could impact the recently achieved 10.6% EBITDA margin?
How will the company balance capital allocation between further densifying its Indian store network (adding 132 stores in Q1) and scaling its Hyderabad manufacturing facility to maintain ROCE above 23%?


































